Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, signaling a refresh of the page's template or related metadata rather than a substantive change to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA recruitment status line 'No longer looking for participants' has been added, indicating enrollment is closed, and new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') have been introduced. The 'Intervention / Treatment' heading has been updated to 'Intervention/Treatment' and the page revision is updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check33 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This update appears to be a maintenance revision rather than a change to the study content.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision label, v3.5.4, appears on the page, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s footer revision/version has been updated from **v3.5.0** to **v3.5.3**.SummaryDifference0.0%

- Check105 days agoChange DetectedAdded Small Cell Lung Carcinoma and Acute Myeloid Leukemia to the study conditions and introduced the Genetic and Rare Diseases Information Center as a new resources entry.SummaryDifference0.1%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.